Prediction of the efficacy of immunotherapy by measuring the integrity of cell‐free DNA in plasma in colorectal cancer

We previously reported a phase II study of a cancer vaccine using five novel peptides recognized by HLA‐A*2402‐restricted CTL in combination with oxaliplatin‐containing chemotherapy (FXV study) as first‐line therapy for patients with metastatic colorectal cancer and demonstrated the safety and promi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitahara, Masahiro, Hazama, Shoichi, Tsunedomi, Ryouichi, Takenouchi, Hiroko, Kanekiyo, Shinsuke, Inoue, Yuka, Nakajima, Masao, Tomochika, Shinobu, Tokuhisa, Yoshihiro, Iida, Michihisa, Sakamoto, Kazuhiko, Suzuki, Nobuaki, Takeda, Shigeru, Ueno, Tomio, Yamamoto, Shigeru, Yoshino, Shigefumi, Nagano, Hiroaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199104/
https://www.ncbi.nlm.nih.gov/pubmed/27663862
http://dx.doi.org/10.1111/cas.13085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5199104/
https://www.ncbi.nlm.nih.gov/pubmed/27663862
http://dx.doi.org/10.1111/cas.13085

Ejemplares similares